A RANDOMIZED PHASE 2 TRIAL OF PF 00299804 VERSUS ERLOTINIB FOR THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER AFTER FAILURE OF AT LEAST ONE PRIOR CHEMOTHERAPY REGIMEN

Update Il y a 4 ans
Reference: EUCTR2008-005235-14

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess Progression Free Survival (PFS) in patients randomized to PF 00299804 and to erlotinib


Inclusion criteria

  • non-small cell lung cancer